Redhill Biopharma
RDHL
$0.43
Share price
2.22%
Change (1 day)
-81.23%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $31.56 M
According to Redhill Biopharma's latest financial reports the company's total liabilities are $31.56 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Redhill Biopharma - Total liabilities on balance sheet (from 2011 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.20 B | 20.29% |
| 2021-12-31 | $0.17 B | 3.57% |
| 2020-12-31 | $0.16 B | 1080.23% |
| 2019-12-31 | $14.09 M | 25.59% |
| 2018-12-31 | $11.22 M | -8.58% |
| 2017-12-31 | $12.27 M | 6.66% |
| 2016-12-31 | $11.51 M | 70.51% |
| 2015-12-31 | $6.75 M | 75.58% |
| 2014-12-31 | $3.84 M | 59.21% |
| 2013-12-31 | $2.41 M | 124.03% |
| 2012-12-31 | $1.07 M | -22.94% |
| 2011-12-31 | $1.39 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $57.61 B | 182,416.00% | 🇫🇷 France |
 Merck MRK | $69.04 B | 218,616.34% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | 186,256.52% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $35.35 B | 111,897.09% | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | $0.38 B | 1,116.77% | 🇮🇱 Israel |